At what enterprise value was APPERTON acquired in 2025?

During the acquisition of APPERTON by EVOLEM in 2025, the transaction's Enterprise Value is estimated to be in the range of 50M - 150M EUR.

What was the EV/EBITDA of APPERTON when it was acquired by EVOLEM?

The estimated EV/EBITDA multiple for APPERTON is in the range of 10x - 18x.

When was APPERTON acquired by EVOLEM?

APPERTON was acquired by EVOLEM in 2025.

What was the revenue of APPERTON at the time of the deal?

The revenue of APPERTON at the time of the deal is estimated to be in the range of 25M - 50M EUR.

What was the EBITDA of APPERTON during the acquisition?

APPERTON's EBITDA is estimated to be in the range of 5M - 25M EUR.

How is the data for the APPERTON acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the APPERTON deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.cfnews.net/L-actualite/LBO/Operations/LBO-bis/Apperton-suture-son-operation-de-MBO-bis-544050

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaAPPERTON

10/2025

APPERTON acquired by EVOLEM

FRANCE Healthcare Services / Sterilization & Hygiene EV 50M - 150M EUR

Context

A French healthcare player specializing in the sterilization of reusable medical equipment has restructured its capital through a secondary MBO. Operating as a mission-critical infrastructure partner within the healthcare sector, the company commands high barriers to entry rooted in stringent clinical regulations and non-discretionary hospital decontamination mandates.

APPERTON, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Apperton is the French leader in the outsourcing of medical device sterilization services for hospitals, private clinics, and medical laboratories. Headquartered in Saint-Priest (near Lyon), the company operates as a critical link in the healthcare supply chain, ensuring that surgical instruments and reusable medical devices (DMR) are decontaminated and sterile for patient safety. Its business model offers two main delivery modes: In Situ (managing the sterilization unit directly within the client's hospital) and Ex Situ (transporting instruments to one of Apperton’s 14 specialized regional centers).

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Healthcare Services

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
11/2025	ASKER HEALTHCARE GROUP	FINMED GROUP	FRANCE	Hospital Logistics
11/2025	EURAZEO	EXCELYA	FRANCE	CRO / Clinical Trials
05/2025	FIVE ARROWS	HUBLO	FRANCE	Health Tech
04/2025	KERSIA	NEOGEN (ANIMAL BIOSECURITY DIVISION)	UNITED STATES	Sterilization & Hygiene
04/2025	TRANSCARENT	ACCOLADE	UNITED STATES	Health Tech
10/2024	Fullscript	Rupa Health	UNITED STATES	Health Tech
07/2024	ARDIAN	MASCO GROUP	ITALY	Healthcare Services
06/2024	PERMIRA	PHARMACORD	UNITED STATES	Health Tech
05/2024	21 INVEST / OAKLEY CAPITAL INVESTMENTS	PRODUCT LIFE	FRANCE	Healthcare Services
10/2023	MOTION EQUITY PARTNERS	BANOOK	FRANCE	CRO / Clinical Trials

REFERENCES

Valuation range: EV 50M - 150M EUR

Revenue range: 25M - 50M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of APPERTON by EVOLEM are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: apperton

Acquirer: evolem